Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elena Maldi

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Journal of Experimental & Clinical Cancer Research : CR|September 2, 2022
The neuronal protein Neuroligin 1 promotes colorectal cancer progression by modulating the APC/β-catenin pathwayMargherita Pergolizzi, Laura Bizzozero, Federica Maione, et al.
Cancers|December 24, 2021
PARP1 Inhibitor and Trabectedin Combination Does Not Increase Tumor Mutational Burden in Advanced Sarcomas-A Preclinical and Translational StudyYmera Pignochino, Giovanni Crisafulli, Giorgia Giordano, et al.
Gastrointestinal Endoscopy|March 29, 2023
Diagnostic accuracy and safety of EUS-guided end-cutting fine-needle biopsy needles for tissue sampling of abdominal and mediastinal lymphadenopathies: a prospective multicenter seriesSilvia Carrara, Daoud Rahal, Kareem Khalaf, et al.
Frontiers in Oncology|September 16, 2022
DNA damage response and repair genes in advanced bone and soft tissue sarcomas: An 8-gene signature as a candidate predictive biomarker of response to trabectedin and olaparib combinationAlessandra Merlini, Maria Laura Centomo, Giulio Ferrero, et al.
Cancers|February 25, 2023
Ki67 as a Predictor of Response to PARP Inhibitors in Platinum Sensitive BRCA Wild Type Ovarian Cancer: The MITO 37 Retrospective StudyValentina Tuninetti, Eleonora Ghisoni, Sandro Pignata, et al.
Cells|February 21, 2020
<i>PIK3R1</i><sup>W624R</sup> Is an Actionable Mutation in High Grade Serous Ovarian CarcinomaConcetta D'Ambrosio, Jessica Erriquez, Maddalena Arigoni, et al.
Nature Communications|March 22, 2022
A non-dividing cell population with high pyruvate dehydrogenase kinase activity regulates metabolic heterogeneity and tumorigenesis in the intestineCarlos Sebastian, Christina Ferrer, Maria Serra, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Journal of Experimental & Clinical Cancer Research : CR|September 2, 2022
The neuronal protein Neuroligin 1 promotes colorectal cancer progression by modulating the APC/β-catenin pathwayMargherita Pergolizzi, Laura Bizzozero, Federica Maione, et al.
Cancers|December 24, 2021
PARP1 Inhibitor and Trabectedin Combination Does Not Increase Tumor Mutational Burden in Advanced Sarcomas-A Preclinical and Translational StudyYmera Pignochino, Giovanni Crisafulli, Giorgia Giordano, et al.
Gastrointestinal Endoscopy|March 29, 2023
Diagnostic accuracy and safety of EUS-guided end-cutting fine-needle biopsy needles for tissue sampling of abdominal and mediastinal lymphadenopathies: a prospective multicenter seriesSilvia Carrara, Daoud Rahal, Kareem Khalaf, et al.
Frontiers in Oncology|September 16, 2022
DNA damage response and repair genes in advanced bone and soft tissue sarcomas: An 8-gene signature as a candidate predictive biomarker of response to trabectedin and olaparib combinationAlessandra Merlini, Maria Laura Centomo, Giulio Ferrero, et al.
Cancers|February 25, 2023
Ki67 as a Predictor of Response to PARP Inhibitors in Platinum Sensitive BRCA Wild Type Ovarian Cancer: The MITO 37 Retrospective StudyValentina Tuninetti, Eleonora Ghisoni, Sandro Pignata, et al.
Cells|February 21, 2020
<i>PIK3R1</i><sup>W624R</sup> Is an Actionable Mutation in High Grade Serous Ovarian CarcinomaConcetta D'Ambrosio, Jessica Erriquez, Maddalena Arigoni, et al.
Nature Communications|March 22, 2022
A non-dividing cell population with high pyruvate dehydrogenase kinase activity regulates metabolic heterogeneity and tumorigenesis in the intestineCarlos Sebastian, Christina Ferrer, Maria Serra, et al.
Pageof 3